Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Cystic fibrosis revisited.

Kulkarni H, Kansra S, Karande S.

J Postgrad Med. 2019 Jun 6. doi: 10.4103/jpgm.JPGM_263_18. [Epub ahead of print] No abstract available.

2.

Comparative potency of obeticholic acid and natural bile acids on FXR in hepatic and intestinal in vitro cell models.

Zhang Y, LaCerte C, Kansra S, Jackson JP, Brouwer KR, Edwards JE.

Pharmacol Res Perspect. 2017 Dec;5(6). doi: 10.1002/prp2.368.

3.

Optimizing Bone Health in Cystic fibrosis: Success is the Sum of Small Efforts.

Kansra S, West N.

Indian Pediatr. 2017 Jul 15;54(7):541. No abstract available.

PMID:
28737138
4.

Vitamin E supplementation in people with cystic fibrosis.

Okebukola PO, Kansra S, Barrett J.

Cochrane Database Syst Rev. 2017 Mar 6;3:CD009422. doi: 10.1002/14651858.CD009422.pub3. Review.

5.

Fifteen-minute consultation: approach to management of respiratory problems in children with neurodisability.

Kansra S, Ugonna K.

Arch Dis Child Educ Pract Ed. 2016 Oct;101(5):226-31. doi: 10.1136/archdischild-2015-308350. Epub 2016 May 5. Review.

PMID:
27150358
6.

Vitamin E supplementation in people with cystic fibrosis.

Okebukola PO, Kansra S, Barrett J.

Cochrane Database Syst Rev. 2014 Dec 9;(12):CD009422. doi: 10.1002/14651858.CD009422.pub2. Review. Update in: Cochrane Database Syst Rev. 2017 Mar 06;3:CD009422.

PMID:
25489958
7.

Difficulties mastered are opportunities won: pulmonologist's perspective.

Kansra S, Aurora P.

Indian Pediatr. 2014 Mar;51(3):176-7. No abstract available.

8.

Biobreeding rat islets exhibit reduced antioxidative defense and N-acetyl cysteine treatment delays type 1 diabetes.

Bogdani M, Henschel AM, Kansra S, Fuller JM, Geoffrey R, Jia S, Kaldunski ML, Pavletich S, Prosser S, Chen YG, Lernmark A, Hessner MJ.

J Endocrinol. 2013 Jan 18;216(2):111-23. doi: 10.1530/JOE-12-0385. Print 2013 Feb.

9.

Identification of a serum-induced transcriptional signature associated with type 1 diabetes in the BioBreeding rat.

Kaldunski M, Jia S, Geoffrey R, Basken J, Prosser S, Kansra S, Mordes JP, Lernmark A, Wang X, Hessner MJ.

Diabetes. 2010 Oct;59(10):2375-85. doi: 10.2337/db10-0372. Epub 2010 Aug 3.

10.

Selective estrogen receptor down-regulator and selective estrogen receptor modulators differentially regulate lactotroph proliferation.

Kansra S, Chen S, Bangaru ML, Sneade L, Dunckley JA, Ben-Jonathan N.

PLoS One. 2010 Apr 19;5(4):e10060. doi: 10.1371/journal.pone.0010060.

11.

Growth suppression of mouse pituitary corticotroph tumor AtT20 cells by curcumin: a model for treating Cushing's disease.

Bangaru ML, Woodliff J, Raff H, Kansra S.

PLoS One. 2010 Apr 13;5(4):e9893. doi: 10.1371/journal.pone.0009893. Erratum in: PLoS One. 2010;5(4). doi:10.1371/annotation/38a101d6-a1f2-4a74-ab63-bc5c61e5f62b.

12.

Curcumin (diferuloylmethane) induces apoptosis and blocks migration of human medulloblastoma cells.

Bangaru ML, Chen S, Woodliff J, Kansra S.

Anticancer Res. 2010 Feb;30(2):499-504.

PMID:
20332461
13.

Epidermal growth factor receptor cross-talks with ligand-occupied estrogen receptor-alpha to modulate both lactotroph proliferation and prolactin gene expression.

Chen S, Bangaru ML, Sneade L, Dunckley JA, Ben-Jonathan N, Kansra S.

Am J Physiol Endocrinol Metab. 2009 Aug;297(2):E331-9. doi: 10.1152/ajpendo.00133.2009. Epub 2009 May 26.

14.

Chronic kidney disease in children following lung and heart-lung transplantation.

Benden C, Kansra S, Ridout DA, Shaw NL, Aurora P, Elliott MJ, Marks SD.

Pediatr Transplant. 2009 Feb;13(1):104-10. doi: 10.1111/j.1399-3046.2008.01060.x. Epub 2008 Dec 12.

PMID:
19087230
15.

Platelets from diabetic pigs exhibit hypersensitivity to thrombin.

Shukla SD, Kansra SV, Reddy MA, Shukla SM, Klachko DM, Sturek M.

Comp Med. 2008 Oct;58(5):481-4.

16.

Estrogen receptor-alpha mediates the epidermal growth factor-stimulated prolactin expression and release in lactotrophs.

Ben-Jonathan N, Chen S, Dunckley JA, LaPensee C, Kansra S.

Endocrinology. 2009 Feb;150(2):795-802. doi: 10.1210/en.2008-0756. Epub 2008 Oct 1.

17.

Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells.

Miller M, Chen S, Woodliff J, Kansra S.

Endocrinology. 2008 Aug;149(8):4158-67. doi: 10.1210/en.2007-1760. Epub 2008 May 1.

18.

Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin.

Rittié L, Kansra S, Stoll SW, Li Y, Gudjonsson JE, Shao Y, Michael LE, Fisher GJ, Johnson TM, Elder JT.

Am J Pathol. 2007 Jun;170(6):2089-99.

19.

Adherence issues in asthma.

Singh M, Kansra S.

Indian Pediatr. 2006 Dec;43(12):1050-5.

20.

Hypocalcaemia following therapy of thyrotoxicosis in an infant.

Kansra S, Devidayal, Suri D, Singh M.

Acta Paediatr. 2006 Mar;95(3):375-7.

PMID:
16497652
21.

Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release.

Kansra S, Yamagata S, Sneade L, Foster L, Ben-Jonathan N.

Mol Cell Endocrinol. 2005 Jul 15;239(1-2):27-36.

PMID:
15950373
22.

Kawasaki disease.

Singh S, Kansra S.

Natl Med J India. 2005 Jan-Feb;18(1):20-4. Review.

PMID:
15835487
23.

Src family kinase inhibitors block amphiregulin-mediated autocrine ErbB signaling in normal human keratinocytes.

Kansra S, Stoll SW, Johnson JL, Elder JT.

Mol Pharmacol. 2005 Apr;67(4):1145-57. Epub 2004 Dec 22.

PMID:
15615697
25.

Keratinocyte outgrowth from human skin explant cultures is dependent upon p38 signaling.

Stoll SW, Kansra S, Elder JT.

Wound Repair Regen. 2003 Sep-Oct;11(5):346-53.

PMID:
12950638
26.

Differential cytoskeletal association of ErbB1 and ErbB2 during keratinocyte differentiation.

Kansra S, Stoll SW, Elder JT.

Biochem Biophys Res Commun. 2002 Aug 2;295(5):1108-17.

PMID:
12135609
27.

Metalloproteinases stimulate ErbB-dependent ERK signaling in human skin organ culture.

Stoll SW, Kansra S, Elder JT.

J Biol Chem. 2002 Jul 26;277(30):26839-45. Epub 2002 May 16.

29.

Bob1, a Gim5/MM-1/Pfd5 homolog, interacts with the MAP kinase kinase Byr1 to regulate sexual differentiation in the fission yeast, Schizosaccharomyces pombe.

Henkel J, Du H, Yang P, Qyang Y, Kansra S, Ko M, Kim HW, Marcus S.

Differentiation. 2001 Jun;67(4-5):98-106.

PMID:
11683500
30.

Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes.

Stoll SW, Kansra S, Peshick S, Fry DW, Leopold WR, Wiesen JF, Sibilia M, Zhang T, Werb Z, Derynck R, Wagner EF, Elder JT.

Neoplasia. 2001 Jul-Aug;3(4):339-50.

31.

IGFBP-3 mediates TGF beta 1 proliferative response in colon cancer cells.

Kansra S, Ewton DZ, Wang J, Friedman E.

Int J Cancer. 2000 Aug 1;87(3):373-8.

32.

Reverse relationship between mitogen activated protein kinase and human platelet aggregation.

Kansra SV, Shukla SD.

Clin Exp Hypertens. 2000 Feb;22(2):145-54.

PMID:
10744355
33.

Activation of mitogen activated protein kinase in human platelets by genistein.

Kansra SV, Reddy MA, Weng YI, Shukla SD.

Pharmacol Res. 1999 Jan;39(1):21-31.

PMID:
10051374
34.

Negative regulation of mitosis in fission yeast by the shk1 interacting protein skb1 and its human homolog, Skb1Hs.

Gilbreth M, Yang P, Bartholomeusz G, Pimental RA, Kansra S, Gadiraju R, Marcus S.

Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14781-6.

35.

Cloning and characterization of shk2, a gene encoding a novel p21-activated protein kinase from fission yeast.

Yang P, Kansra S, Pimental RA, Gilbreth M, Marcus S.

J Biol Chem. 1998 Jul 17;273(29):18481-9.

36.

Potentiation of cyclic adenosine monophosphate production by thrombin in the human erythroleukemia cell line, HEL.

Turner JT, Camden JM, Kansra S, Shelton-James D, Wu H, Halenda SP.

J Pharmacol Exp Ther. 1992 Nov;263(2):708-16.

PMID:
1331412

Supplemental Content

Loading ...
Support Center